Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol.
D000614:Aminocaproates / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000032:analysis; D004285:Dogs; D005169:Factor VIII / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D013917:Thrombin / Q000032:analysis / Q000494:pharmacology; D013925:Thromboplastin / Q000494:pharmacology
D000614:Aminocaproates; D005169:Factor VIII; D005340:Fibrinogen; D006493:Heparin; D013925:Thromboplastin; D007611:Aprotinin; D013917:Thrombin